ex·clu·sivi·ty (n.) – period of uniqueness, typically accompanied by envy and profit

FDA recognizes data and market exclusivity in its drug approval process, which emanated from laws encouraging the development of drugs for rare diseases and allowing for generic drugs, although the terms themselves do not appear in the bills.